tiprankstipranks
Advertisement
Advertisement

WVE Stock Latest News

Alec Stranahan Maintains Buy Rating on Wave Life Sciences with Unchanged $17 Price Target Amid Multiple Clinical Catalysts
RatingsAlec Stranahan Maintains Buy Rating on Wave Life Sciences with Unchanged $17 Price Target Amid Multiple Clinical Catalysts
7d ago
WVE
Wave Life Sciences announces completion of redomiciliation to Delaware
PremiumThe Fly
Wave Life Sciences announces completion of redomiciliation to Delaware
9d ago
WVE
Wave Life Sciences price target lowered to $23 from $27 at Mizuho
PremiumThe Fly
Wave Life Sciences price target lowered to $23 from $27 at Mizuho
15d ago
WVE
Analyst Reiterates Buy on Wave’s WVE-007, Maintaining Unchanged $13 Price Target Amid Enhanced Phase 2a INLIGHT Design
PremiumRatings
Analyst Reiterates Buy on Wave’s WVE-007, Maintaining Unchanged $13 Price Target Amid Enhanced Phase 2a INLIGHT Design
19d ago
WVE
Wave Life Sciences price target raised to $22 from $21 at B. Riley
PremiumThe Fly
Wave Life Sciences price target raised to $22 from $21 at B. Riley
19d ago
WVE
Wave Life Sciences price target lowered to $12 from $15 at Wedbush
PremiumThe FlyWave Life Sciences price target lowered to $12 from $15 at Wedbush
19d ago
WVE
Wave Life Sciences price target lowered to $19 from $24 at Citi
Premium
The Fly
Wave Life Sciences price target lowered to $19 from $24 at Citi
19d ago
WVE
Wave Life Sciences’ Earnings Call Highlights RNA Momentum
Premium
Company Announcements
Wave Life Sciences’ Earnings Call Highlights RNA Momentum
20d ago
WVE
Wave Life Sciences price target lowered to $26 from $36 at Clear Street
PremiumThe Fly
Wave Life Sciences price target lowered to $26 from $36 at Clear Street
20d ago
WVE
Wave Life Sciences posts Q2 results, pipeline update
PremiumCompany Announcements
Wave Life Sciences posts Q2 results, pipeline update
20d ago
8K
WVE
Wave Life Sciences reports Q2 EPS (34c), consensus (30c)
PremiumThe Fly
Wave Life Sciences reports Q2 EPS (34c), consensus (30c)
20d ago
WVE
Wave Life Sciences Shareholders Approve Redomiciliation Scheme
PremiumCompany Announcements
Wave Life Sciences Shareholders Approve Redomiciliation Scheme
2M ago
8K
WVE
Wave Life Sciences initiates multidose portion of Inlight trial
PremiumThe FlyWave Life Sciences initiates multidose portion of Inlight trial
2M ago
WVE
Wave Life Sciences: Buy Rating Reiterated on Differentiated Obesity Profile; $13 Price Target Unchanged
Premium
Ratings
Wave Life Sciences: Buy Rating Reiterated on Differentiated Obesity Profile; $13 Price Target Unchanged
2M ago
WVE
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
3M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
3M ago
AZN
BMY
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts
3M ago
WVE
REAX
Wave Life Sciences price target raised to $14 from $13 at Wells Fargo
PremiumThe Fly
Wave Life Sciences price target raised to $14 from $13 at Wells Fargo
3M ago
WVE
Wave Life Sciences Signals Momentum in Earnings Call
PremiumCompany Announcements
Wave Life Sciences Signals Momentum in Earnings Call
3M ago
WVE
Wave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright
PremiumThe FlyWave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright
3M ago
WVE
Wave Life Sciences: Buy Rating Reaffirmed as WVE-006 Data Strengthen Case for Accelerated Pathway; $15 Price Target Maintained
Premium
Ratings
Wave Life Sciences: Buy Rating Reaffirmed as WVE-006 Data Strengthen Case for Accelerated Pathway; $15 Price Target Maintained
3M ago
WVE
Wave Life Sciences advances WVE-006 RNA editing trial
Premium
Company Announcements
Wave Life Sciences advances WVE-006 RNA editing trial
3M ago
8K
WVE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >